The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 323.10
+0.20 (0.06%)
At close: Mar 4, 2026
DSE:IBNSINA Market Cap
DSE:IBNSINA has a market cap or net worth of 10.09 billion as of March 4, 2026. Its market cap has increased by 10.46% in one year.
Market Cap
10.09B
Enterprise Value
12.65B
Revenue
13.42B
Ranking
n/a
PE Ratio
12.38
Stock Price
323.10
Market Cap Chart
Since May 3, 2012, DSE:IBNSINA's market cap has increased from 1.73B to 10.09B, an increase of 483.46%. That is a compound annual growth rate of 13.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 10.09B | 2.83% |
| Dec 30, 2025 | 9.81B | 9.48% |
| Dec 30, 2024 | 8.96B | 0.07% |
| Dec 28, 2023 | 8.95B | - |
| Dec 29, 2022 | 8.95B | 5.64% |
| Dec 30, 2021 | 8.48B | 11.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 56.66B |
| Renata | 51.45B |
| Unilever Consumer Care | 42.15B |
| Beacon Pharmaceuticals | 24.39B |
| The ACME Laboratories | 16.82B |
| Asiatic Laboratories | 7.44B |
| Orion Pharma | 7.23B |
| Navana Pharmaceuticals | 6.53B |